McCann FitzGerald LLP advises Mainstay Medical Holdings plc on an equity financing that raised gross proceeds of US$125 million

Mainstay intends to use the funds to support the company’s continued commercial growth of ReActiv8® Restorative Neurostimulation in the U.S., Europe and Australia, additional post-market clinical studies and research, and general operations. The financing was co-led by new investors Gilde Healthcare and Viking Global Investors. Key existing investors who participated in the financing include Ally Bridge Group, Sofinnova Partners (Crossover Fund), Fountain Healthcare Partners, and Perceptive Advisors.

The McCann FitzGerald LLP team was led by Stephen FitzSimons and Jack Kelly.